Cargando…

Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications

While SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) as the receptor for cell entry, it is important to examine other potential interactions between the virus and other cell receptors. Based on the clinical observation of low prevalence of smoking among hospitalized COVID-19 patients, we exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Farsalinos, Konstantinos, Eliopoulos, Elias, Leonidas, Demetres D., Papadopoulos, Georgios E., Tzartos, Socrates, Poulas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461543/
https://www.ncbi.nlm.nih.gov/pubmed/32823591
http://dx.doi.org/10.3390/ijms21165807
_version_ 1783576757616508928
author Farsalinos, Konstantinos
Eliopoulos, Elias
Leonidas, Demetres D.
Papadopoulos, Georgios E.
Tzartos, Socrates
Poulas, Konstantinos
author_facet Farsalinos, Konstantinos
Eliopoulos, Elias
Leonidas, Demetres D.
Papadopoulos, Georgios E.
Tzartos, Socrates
Poulas, Konstantinos
author_sort Farsalinos, Konstantinos
collection PubMed
description While SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) as the receptor for cell entry, it is important to examine other potential interactions between the virus and other cell receptors. Based on the clinical observation of low prevalence of smoking among hospitalized COVID-19 patients, we examined and identified a “toxin-like” amino acid (aa) sequence in the Receptor Binding Domain of the Spike Glycoprotein of SARS-CoV-2 (aa 375–390), which is homologous to a sequence of the Neurotoxin homolog NL1, one of the many snake venom toxins that are known to interact with nicotinic acetylcholine receptors (nAChRs). We present the 3D structural location of this “toxin-like” sequence on the Spike Glycoprotein and the superposition of the modelled structure of the Neurotoxin homolog NL1 and the SARS-CoV-2 Spike Glycoprotein. We also performed computational molecular modelling and docking experiments using 3D structures of the SARS-CoV-2 Spike Glycoprotein and the extracellular domain of the nAChR α9 subunit. We identified a main interaction between the aa 381–386 of the SARS-CoV-2 Spike Glycoprotein and the aa 189–192 of the extracellular domain of the nAChR α9 subunit, a region which forms the core of the “toxin-binding site” of the nAChRs. The mode of interaction is very similar to the interaction between the α9 nAChR and α-bungarotoxin. A similar interaction was observed between the pentameric α7 AChR chimera and SARS-CoV-2 Spike Glycoprotein. The findings raise the possibility that SARS-CoV-2 may interact with nAChRs, supporting the hypothesis of dysregulation of the nicotinic cholinergic system being implicated in the pathophysiology of COVID-19. Nicotine and other nicotinic cholinergic agonists may protect nAChRs and thus have therapeutic value in COVID-19 patients.
format Online
Article
Text
id pubmed-7461543
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74615432020-09-04 Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications Farsalinos, Konstantinos Eliopoulos, Elias Leonidas, Demetres D. Papadopoulos, Georgios E. Tzartos, Socrates Poulas, Konstantinos Int J Mol Sci Article While SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) as the receptor for cell entry, it is important to examine other potential interactions between the virus and other cell receptors. Based on the clinical observation of low prevalence of smoking among hospitalized COVID-19 patients, we examined and identified a “toxin-like” amino acid (aa) sequence in the Receptor Binding Domain of the Spike Glycoprotein of SARS-CoV-2 (aa 375–390), which is homologous to a sequence of the Neurotoxin homolog NL1, one of the many snake venom toxins that are known to interact with nicotinic acetylcholine receptors (nAChRs). We present the 3D structural location of this “toxin-like” sequence on the Spike Glycoprotein and the superposition of the modelled structure of the Neurotoxin homolog NL1 and the SARS-CoV-2 Spike Glycoprotein. We also performed computational molecular modelling and docking experiments using 3D structures of the SARS-CoV-2 Spike Glycoprotein and the extracellular domain of the nAChR α9 subunit. We identified a main interaction between the aa 381–386 of the SARS-CoV-2 Spike Glycoprotein and the aa 189–192 of the extracellular domain of the nAChR α9 subunit, a region which forms the core of the “toxin-binding site” of the nAChRs. The mode of interaction is very similar to the interaction between the α9 nAChR and α-bungarotoxin. A similar interaction was observed between the pentameric α7 AChR chimera and SARS-CoV-2 Spike Glycoprotein. The findings raise the possibility that SARS-CoV-2 may interact with nAChRs, supporting the hypothesis of dysregulation of the nicotinic cholinergic system being implicated in the pathophysiology of COVID-19. Nicotine and other nicotinic cholinergic agonists may protect nAChRs and thus have therapeutic value in COVID-19 patients. MDPI 2020-08-13 /pmc/articles/PMC7461543/ /pubmed/32823591 http://dx.doi.org/10.3390/ijms21165807 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Farsalinos, Konstantinos
Eliopoulos, Elias
Leonidas, Demetres D.
Papadopoulos, Georgios E.
Tzartos, Socrates
Poulas, Konstantinos
Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
title Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
title_full Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
title_fullStr Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
title_full_unstemmed Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
title_short Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
title_sort nicotinic cholinergic system and covid-19: in silico identification of an interaction between sars-cov-2 and nicotinic receptors with potential therapeutic targeting implications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461543/
https://www.ncbi.nlm.nih.gov/pubmed/32823591
http://dx.doi.org/10.3390/ijms21165807
work_keys_str_mv AT farsalinoskonstantinos nicotiniccholinergicsystemandcovid19insilicoidentificationofaninteractionbetweensarscov2andnicotinicreceptorswithpotentialtherapeutictargetingimplications
AT eliopouloselias nicotiniccholinergicsystemandcovid19insilicoidentificationofaninteractionbetweensarscov2andnicotinicreceptorswithpotentialtherapeutictargetingimplications
AT leonidasdemetresd nicotiniccholinergicsystemandcovid19insilicoidentificationofaninteractionbetweensarscov2andnicotinicreceptorswithpotentialtherapeutictargetingimplications
AT papadopoulosgeorgiose nicotiniccholinergicsystemandcovid19insilicoidentificationofaninteractionbetweensarscov2andnicotinicreceptorswithpotentialtherapeutictargetingimplications
AT tzartossocrates nicotiniccholinergicsystemandcovid19insilicoidentificationofaninteractionbetweensarscov2andnicotinicreceptorswithpotentialtherapeutictargetingimplications
AT poulaskonstantinos nicotiniccholinergicsystemandcovid19insilicoidentificationofaninteractionbetweensarscov2andnicotinicreceptorswithpotentialtherapeutictargetingimplications